Edition:
United States

Insider Trading: Opiant Pharmaceuticals Inc (OPNT.O)

OPNT.O on Consolidated Issue listed on NASDAQ Capital Market

36.97USD
21 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$36.97
Open
--
Day's High
--
Day's Low
--
Volume
24
Avg. Vol
49,344
52-wk High
$51.90
52-wk Low
$5.00

All Insider Trades
Trading Date Name Title Type Shares Traded Price
16 Jan 2017

Crystal (Roger)

Chief Executive Officer Buy 3,475 $6.99
16 Jan 2017

Sinclair (Michael)

Officer, Director and Beneficial Owner Buy 3,500 $7.01
12 Jan 2017

Pollack (Kevin A)

Chief Financial Officer Buy 4,820 $6.98

Institutional Holders

% Shares Owned: 1.32%
# of Holders: 1
Total Shares Held: 26,850
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

Michael Sinclair

73 2012 Executive Chairman of the Board

Roger Crystal

38 2009 President, Chief Executive Officer, Director

David O'Toole

58 2017 Chief Financial Officer

Arvind Agrawal

2015 Executive Vice President - Medical Affairs

Phil Skolnick

69 2017 Chief Scientific Officer

Ann MacDougall

2016 Director

Gabrielle Silver

42 2016 Director

Thomas Thomas

2016 Director

Geoffrey Wolf

61 2012 Director

Michael Porter

IR Contact Officer